Tamthom Ngo Truong

Array ( [id] => 7180566 [patent_doc_number] => 20050124562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Bis-quinazoline compounds for the treatment of bacterial infections' [patent_app_type] => utility [patent_app_number] => 10/948110 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27664 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124562.pdf [firstpage_image] =>[orig_patent_app_number] => 10948110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688980 [patent_doc_number] => 20060287295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Quinazoline derivatives as antiproliferative agents' [patent_app_type] => utility [patent_app_number] => 10/572794 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36883 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287295.pdf [firstpage_image] =>[orig_patent_app_number] => 10572794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477567 [patent_doc_number] => 07906521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Quinazoline potassium channel inhibitors' [patent_app_type] => utility [patent_app_number] => 10/572341 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11897 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906521.pdf [firstpage_image] =>[orig_patent_app_number] => 10572341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154954 [patent_doc_number] => 20070037837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/572048 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21913 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037837.pdf [firstpage_image] =>[orig_patent_app_number] => 10572048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163455 [patent_doc_number] => 20050085495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Process for preparing amino crotonyl compounds' [patent_app_type] => utility [patent_app_number] => 10/941116 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3105 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085495.pdf [firstpage_image] =>[orig_patent_app_number] => 10941116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051963 [patent_doc_number] => 20070032508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Quinazoline derivatives as tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/571851 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55660 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032508.pdf [firstpage_image] =>[orig_patent_app_number] => 10571851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693943 [patent_doc_number] => 20070015743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Quinazoline derivatives as antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/572262 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72320 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015743.pdf [firstpage_image] =>[orig_patent_app_number] => 10572262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263812 [patent_doc_number] => 07569577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Quinazoline derivatives as tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/573090 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49852 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569577.pdf [firstpage_image] =>[orig_patent_app_number] => 10573090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051968 [patent_doc_number] => 20070032513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/572261 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37077 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032513.pdf [firstpage_image] =>[orig_patent_app_number] => 10572261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145552 [patent_doc_number] => 20050119231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Quinolone antibacterial agents' [patent_app_type] => utility [patent_app_number] => 10/936223 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26141 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119231.pdf [firstpage_image] =>[orig_patent_app_number] => 10936223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918747 [patent_doc_number] => 20050096308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Antibacterial agents' [patent_app_type] => utility [patent_app_number] => 10/936222 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9295 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096308.pdf [firstpage_image] =>[orig_patent_app_number] => 10936222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163279 [patent_doc_number] => 20050085459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4' [patent_app_type] => utility [patent_app_number] => 10/936070 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28951 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085459.pdf [firstpage_image] =>[orig_patent_app_number] => 10936070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912977 [patent_doc_number] => 20050176735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Polymorphs of zaleplon and methods for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/924436 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6846 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176735.pdf [firstpage_image] =>[orig_patent_app_number] => 10924436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 224982 [patent_doc_number] => 07605165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Phenylalanine derivatives' [patent_app_type] => utility [patent_app_number] => 10/921929 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29296 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605165.pdf [firstpage_image] =>[orig_patent_app_number] => 10921929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478910 [patent_doc_number] => 07223767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists' [patent_app_type] => utility [patent_app_number] => 10/916582 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11033 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223767.pdf [firstpage_image] =>[orig_patent_app_number] => 10916582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627092 [patent_doc_number] => 07135476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists' [patent_app_type] => utility [patent_app_number] => 10/916583 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9327 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135476.pdf [firstpage_image] =>[orig_patent_app_number] => 10916583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580671 [patent_doc_number] => 07452895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Quinazoline analogs as receptor tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/914974 [patent_app_country] => US [patent_app_date] => 2004-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18899 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452895.pdf [firstpage_image] =>[orig_patent_app_number] => 10914974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7156316 [patent_doc_number] => 20050026942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Chemokine receptor binding heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/914663 [patent_app_country] => US [patent_app_date] => 2004-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43748 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026942.pdf [firstpage_image] =>[orig_patent_app_number] => 10914663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733576 [patent_doc_number] => 20060258693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Halogenated quinazolinyl nitrofurans as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 10/567660 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8625 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258693.pdf [firstpage_image] =>[orig_patent_app_number] => 10567660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 868686 [patent_doc_number] => 07365073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => '3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4' [patent_app_type] => utility [patent_app_number] => 10/898576 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29535 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365073.pdf [firstpage_image] =>[orig_patent_app_number] => 10898576 [rel_patent_id] =>[rel_patent_doc_number] =>)